|
|
|
|
|
Detail |
hsa-miR-16 |
|
Unspecified |
MicroRNA expression profiling in prostate cancer. |
2007 |
|
|
|
|
|
|
hsa-miR-16 |
|
Causal |
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. |
2002 |
|
|
|
|
|
|
hsa-miR-16 |
|
Causal |
Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. |
2007 |
|
|
|
|
|
|
hsa-miR-16 |
|
Causal |
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. |
2008 |
|
|
|
|
|
|
hsa-miR-16 |
|
Causal |
miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. |
2009 |
|
|
|
|
|
|
hsa-miR-16 |
|
Unspecified |
MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. |
2009 |
|
|
|
|
|
|
hsa-miR-16 |
|
Unspecified |
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. |
2009 |
|
|
|
|
|
|
hsa-miR-16 |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
hsa-miR-16 |
|
Unspecified |
miRNA Expression in a Human Papillary Thyroid Carcinoma Cell Line Varies with Invasiveness |
2009 |
|
|
|
|
|
|
hsa-miR-16 |
|
Unspecified |
MicroRNA expression profiles in serous ovarian carcinoma. |
2008 |
|
|
|
|
|
|
hsa-miR-16 |
|
Unspecified |
MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. |
2008 |
|
|
|
|
|
|
hsa-miR-16 |
|
Causal |
Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in
human cancer cells. |
2009 |
|
|
|
|
|
|
hsa-miR-16 |
|
Unspecified |
The expression profile of microRNAs in a model of
7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. |
2009 |
|
|
|
|
|
|
hsa-miR-16 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
hsa-miR-16 |
|
Causal |
Systemic Delivery of Synthetic MicroRNA-16 Inhibits the Growth of Metastatic Prostate Tumors via Downregulation of Multiple Cell-cycle Genes |
2009 |
|
|
|
|
|
|
hsa-miR-16 |
|
Unspecified |
Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas |
2009 |
|
|
|
|
|
|